Aims and Scope

Journal covers the following interest areas and sub-areas in Acta Pharma Reports:

Aims and Scope of the Journal

Acta Pharma Reports is a biannually peer-reviewed multi-disciplinary pharmaceutical publication to serve as a means for scientific information exchange in the international pharmaceutical forum. It accepts novel findings that contribute to advancement of scientific knowledge in pharmaceutical fields that not been published or under consideration for publication anywhere else for publication in JRPS as original research article and all aspects of pharmaceutical sciences consisting of medicinal chemistry, molecular modeling, drug design, pharmaceutics, bio-pharmacy, pharmaceutical nanotechnology, pharmacognosy, natural products, pharmaceutical biotechnology, pharmacology, toxicology and clinical pharmacy.

Abstracting and Indexing Information

The journal is registered with the following abstracting partners:
American Society of Health System Pharmacists, Baidu Scholar, Previews, CNKI (China National Knowledge Infrastructure Ex Libris – Primo Central, Google Scholar, Hinari, Infotrieve, National Science Library, ProQuest, TDNet, Wanfang Data

Journal Ethics

Wolters Kluwer and Journal/Association are committed to meeting and upholding standards of ethical behavior at all stages of the publication process. We follow closely the industry associations, such as the Committee on Publication Ethics (COPE), International Committee of Medical Journal Editors (ICMJE) , and World Association of Medical Editors (WAME), that set standards and provide guidelines for best practices to meet these requirements. For a summary of our specific policies regarding duplicate publication, conflicts of interest, patient consent, etc.,

Open Access Publication and Creative Commons Licensing

This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Digital Archiving

Acta Pharma Reports provides for long-term digital preservation through two primary partnerships, Portico and CLOCKSS.

Portico is a leading digital preservation service worldwide. The content is preserved as an archival version and is not publically accessible via Portico, but is provided when required under specific conditions, such as discontinuation of the collection or catastrophic failure of the website.

CLOCKSS will enable any library to maintain their own archive of content from Acta Pharma Reports and other publishers, with minimal technical effort and using cheaply available hardware.

Ahead of Print Policy

Articles published online under the Ahead of Print model are considered published and can be cited and quoted using the DOI as the reference source. Acta Pharma Reports has a policy that changes will not be made after publication of an article without following accepted procedures for making corrections to the scientific record.

Advertisements